openPR Logo
Press release

Dermatomyositis Treatment Market Size, Share & Trend | Industry Report, 2017-2025

01-19-2018 08:02 AM CET | Health & Medicine

Press release from: TMR

/ PR Agency: TMR
Dermatomyositis Treatment Market Size, Share & Trend | Industry

Dermatomyositis is a form of inflammatory myopathy in which degenerative and inflammatory changes occur in the skin and the muscles. It is a rare form of acquired muscle disease that is accompanied by skin rashes. Symptoms of dermatomyositis may vary broadly from patient to patient. Deformities in the muscles may initiate with weakness and pain in the muscles of the thighs (proximal muscles), the hips, the upper arms, and the trunk. The muscles may become tender, sore, and stiff and eventually, they may express signs of degeneration (atrophy). Persons affected by dermatomyositis may experience struggle in the execution of certain tasks such as swallowing, or/and speaking, or/and climbing stairs, or/and raising their arms. Deformities in the skin often comprise typical, reddish-purple-colored, heliotrope rashes across the cheeks or on the upper portion of the eyelid (heliotrope eyelids), on the scalp and parts of the forehead, and on bridge of the nose, showing a ‘butterfly’ form of distribution. Several other distinctive rashes comprise redness and scaling of the knees, the elbows, the knuckles, or/and other expander regions (Gottron’s papules); an unusual agglomeration of fluid (edema) in body tissues nearby the eyes; or/and several other characteristics.

Request to view Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37076

Symptoms of juvenile or childhood dermatomyositis are similar to those of the adult form of the disease. However, in children, the onset is generally quicker. In addition, calcification or atypical deposition of calcium in the skin and muscle tissues is common in dermatomyositis. Also, involvement of the gastrointestinal (GI) tract is more common in this condition. Moreover, in some patients with dermatomyositis, there may be a correlation to an underlying malignancy (cancer). Several researches reveal that cancer may occur following the onset of dermatomyositis. Cancer-related dermatomyositis is observed to occur more frequently in persons aged between 40 and 50 years. Though there is no characteristic cancer type or site, specialists specify that underlying cancers can most commonly grow in the testes, the ovaries, the breasts, the lungs, the GI tract, or some lymphoid tissues (in case of multiple myeloma, certain lymphomas, and leukemia) or lymphocytes (white blood cells).

According to Rare Disease Organization, the rate of incidence of dermatomyositis is estimated to be around 9.63 cases per million people globally. In children, dermatomyositis symptoms commonly occur between 5 and 15 years of age. Around three in 1,000,000 children are affected by juvenile dermatomyositis. In women, chances of dermatomyositis are two times greater than those in men. The global dermatomyositis treatment market is expanding rapidly, due to rising awareness about the disease and availability of treatments. Moreover, genetic mutations and several other factors that cause immune problems drive the global market for dermatomyositis treatment. In developing countries, unawareness about the disease restrains the market.

The global dermatomyositis treatment market can be segmented based on type of medication, distribution channel, and geography. In terms of type of medication, the market can be classified into pharmacotherapy and non-pharmacotherapy. The pharmacotherapy segment can be sub-classified into corticosteroids, immunosuppressive agents, immune globulins, and antimalarial agents. The non-pharmacotherapy segment can be sub-divided into general therapeutic measures and surgery. Based on distribution channel, the global dermatomyositis treatment market can be segregated into hospital pharmacy, retail pharmacy, and online pharmacy.

Geographically, the global dermatomyositis treatment market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market due to advanced lifestyle and awareness among the people in the region. Development of advanced medications and diagnostic tests is a major factor driving the market in the region. The market in Asia Pacific is expected to expand at a high growth rate during the forecast period, due to presence of rapidly developing economies such as China and India in the region.

 
View Report @ https://www.transparencymarketresearch.com/dermatomyositis-treatment-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dermatomyositis Treatment Market Size, Share & Trend | Industry Report, 2017-2025 here

News-ID: 908275 • Views:

More Releases from TMR

Emerging Opportunities in Logistics Market with Current Trends Analysis
Emerging Opportunities in Logistics Market with Current Trends Analysis
The global Logistics market is estimated to attain a valuation of US$ 15,273.21 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.5% during the forecast period, 2019-2027. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the
Energy Measurement IC Market is expected to reach US$ 8.39 Bn by the end of 2031
According to a Transparency Market Research (TMR) research report, the global energy measurement ic market is likely to expand at a CAGR of 7.4% during the forecast period, 2022 to 2031. This suggests that the market is expected to reach US$ 8.39 Bn by the end of 2031. The study on the energy measurement ic market adopts rigorous and systematic research approaches to understand the growth dynamic of the market. The
STATCOM UPS Market to Register Double Digit Growth Rate of 16% CAGR by 2024
Over the last decade, rising number of industries and utilities are opting for static synchronous compensator or STATCOM UPS instead of static VAR compensator or SVC UPS. Low harmonic emission coupled with high speed of response is accentuating the expansion of India STATCOM UPS market now and in times to come. Playing a crucial role in voltage control and compensation of reactive power, STATCOM UPS is likely to keep its
Thin Wafer Processing and Dicing Equipment Market US$692.5 mn by 2024 - TMR
Transparency Market Research (TMR) estimates that the global thin wafer processing and dicing equipment market has a highly consolidative landscape. Disco Corp. accounted for largest share of 56.4% in 2015 and likely to be dominant in the coming years. This is creating monopoly in the thin wafer processing and dicing equipment market in terms of competitive presence. The other key players such as EV Group, Plasma-Therm LLC, Lam Research Corp,

All 5 Releases


More Releases for Dermatomyositis

Dermatomyositis Treatment Market – segmentation up to the second or third leve …
Dermatomyositis is a form of inflammatory myopathy in which degenerative and inflammatory changes occur in the skin and the muscles. It is a rare form of acquired muscle disease that is accompanied by skin rashes. Symptoms of dermatomyositis may vary broadly from patient to patient. Deformities in the muscles may initiate with weakness and pain in the muscles of the thighs (proximal muscles), the hips, the upper arms, and the
Dermatomyositis Treatment Market– Current Trends, Opportunities & Challenges b …
The report analyzes and presents an overview of "Dermatomyositis Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025" worldwide. The objectives of this study are as follows: To define, describe, and forecast the "Dermatomyositis Treatment" market by type, application, component, delivery model, end user, and region To provide detailed information regarding major factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges) To analyze micromarkets with respect to
Dermatomyositis Treatment Market - New Products Features & Forecast 2017 - 2025
Dermatomyositis is a form of inflammatory myopathy in which degenerative and inflammatory changes occur in the skin and the muscles. It is a rare form of acquired muscle disease that is accompanied by skin rashes. Symptoms of dermatomyositis may vary broadly from patient to patient. Deformities in the muscles may initiate with weakness and pain in the muscles of the thighs (proximal muscles), the hips, the upper arms, and the
Dermatomyositis Drug Sales Market 2022 - Opportunities, Challenges, Strategies, …
Report Bazzar has released its latest research-based report entitled ‘Dermatomyositis Drug Sales market.' This comprehensive report provides a holistic approach to the market growth with a detailed and precise analysis of the overall competitive scenario of the Dermatomyositis Drug Sales Market worldwide along with the key trends and latest technologies, playing a prominent role in the Dermatomyositis Drug Sales market growth over the predicted period. It also takes into account
Global Dermatomyositis Drug Market Size, Share, Outlook and Forecast Report 2017
The research report on the Global dermatomyositis drug market research report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of “Global dermatomyositis drug market research report 2017” and provides deep insights into
Global Dermatomyositis - Pipeline Insight and Therapeutic Assessment Reviewed in …
A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Dermatomyositis - Pipeline Review, H2 2017”which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the sector for pharmaceutical industry would rise at a positive CAGR during the period 2017-2022. Click here for Free